eScholarship
metadata only
Cardiovascular Toxicity of Antibody-Drug Conjugates in Breast Cancer Current Evidence and Evolving Considerations: JACC: CardioOncology Primer
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Subcutaneous administration of antibody-drug conjugates: current challenges, emerging opportunities, and future perspectives.#452916
- Comparative Study Between (SGLT-2i) and (DPP-4i) in the Prevention of DIC#1073265
- Cardioprotective Effects of Nebivolol Versus Placebo in Patients Undergoing Chemotherapy With Anthracyclines#878365
- Bevacizumab and Abraxane as Second-line Therapy in Triple Negative Metastatic Breast Cancer#885276
- Antibody-Drug Conjugates and Peptide-Drug Conjugates: Current Understandings and Future Perspectives.#433837
Record · ID 675936
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive